Astressin-B
Overview[edit | edit source]
Astressin-B is a potent and long-acting corticotropin-releasing hormone receptor (CRHR) antagonist. It is a peptide that has been studied for its potential therapeutic effects in various stress-related disorders. Astressin-B is known for its ability to block the action of corticotropin-releasing hormone (CRH), which plays a significant role in the body's response to stress.
Structure and Function[edit | edit source]
Astressin-B is a cyclic peptide that is derived from the original peptide astressin. It has been modified to enhance its stability and potency. The molecular structure of Astressin-B allows it to bind effectively to CRH receptors, particularly CRHR1 and CRHR2, inhibiting their activation by CRH.
The primary function of Astressin-B is to mitigate the effects of stress by blocking the CRH receptors. This action can potentially reduce the release of adrenocorticotropic hormone (ACTH) from the pituitary gland, subsequently decreasing the production of cortisol from the adrenal glands.
Applications in Research[edit | edit source]
Astressin-B has been extensively used in preclinical research to study its effects on stress-related conditions. It has shown promise in animal models for reducing anxiety-like behaviors and preventing stress-induced hair loss.
In studies involving rodents, administration of Astressin-B has been associated with a reduction in stress-induced gastrointestinal disorders, such as irritable bowel syndrome (IBS). Its ability to cross the blood-brain barrier makes it a valuable tool for investigating central nervous system effects of CRH antagonism.
Potential Therapeutic Uses[edit | edit source]
The potential therapeutic uses of Astressin-B are being explored in various fields. Its ability to modulate the stress response suggests it could be beneficial in treating conditions such as anxiety disorders, depression, and post-traumatic stress disorder (PTSD).
Additionally, due to its effects on hair growth, there is interest in its application for treating certain types of alopecia. However, further research and clinical trials are necessary to fully understand its efficacy and safety in humans.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
